Cite
HARVARD Citation
Machado, D. et al. (n.d.). 229PEvaluation of human epidermal growth factor receptor 2 overexpression (HER2+) after administration of neoadjuvant treatment (NAT) and prognostic impact in breast cancer (BC). Annals of oncology. p. . [Online].